Navigating Continuous Glucose Monitoring Adoption: Insights From Hispanic Adults With Insulin‐Treated Type 2 Diabetes
Journal of Diabetes Research · 2026-01 · 2026 (1)
DOI: 10.1155/jdr/7474846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, online erschienen am 24.04.2026. Verfasst von Diana Soliman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Leonard M. Miller School of Medicine, Miami, Florida,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Continuous Glucose Monitoring, Hispanic or Latino, Insulin. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
Hispanic individuals are disproportionately affected by type 2 diabetes (T2D) and face access limitations in diabetes technology utilization. Despite proven benefits, continuous glucose monitoring (CGM) use remains low among Hispanic adults with insulin‐treated T2D. This study used a social–ecological model (SEM) framework to identify societal/policy, interpersonal/community, and individual level barriers to CGM access and adoption within this population.
Methods
Two focus groups were conducted in Spanish at the University of Miami (UM) with Hispanic adults ( n = 16) with T2D. Inclusion criteria were age ≥18 years, HbA1c ≥8%, ≥1 daily insulin injection, and no CGM use in the past 2 years. The initial focus group was conducted to identify barriers to CGM initiation. At the end of the focus group, participants were provided with real‐time CGMs for 30 days of use. After completing the wear period, the same participants returned for a follow‐up focus group to explore factors related to CGM adoption and acceptance. Focus groups were analyzed using a thematic analysis, systematically coding and categorizing key concepts and ideas expressed by participants.
Results
The mean age was 59.68 ± 13.37 years, and baseline HbA1c was 9.78 ± 1.14. Key barriers included high device costs, limited insurance coverage, alarm fatigue, and lack of culturally concordant provider guidance. Facilitators for CGM use included manufacturer discounts, peer modeling, and the desire to avoid fingersticks. After a 30‐day CGM trial, most participants reported improved dietary awareness, glycemic control, and a strong desire for continued use.
Conclusion
This pilot study provides novel insights into the experiences of the Hispanic population and highlights the complex interplay of societal, interpersonal, and individual‐level factors influencing CGM use. Tailored interventions addressing these barriers are crucial for improving CGM utilization in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA, miami.edu.
- Department of Health Services Research, Management and Policy, University of Florida, Gainesville, Florida, USA, ufl.edu.
- Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA, miami.edu.
- Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA, emory.edu.
ORCID-Profile: Diana Soliman, Rodolfo J Galindo
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health
Zitieren
APA
Soliman, D., Arevalo, G., Galindo, R. J., Churba, B., Malden, K. G., Jimenez, D. E., Pasquel, F. J., Baidal, D. A., & Walker, A. F. (2026). Navigating Continuous Glucose Monitoring Adoption: Insights From Hispanic Adults With Insulin‐Treated Type 2 Diabetes. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/7474846
Vancouver
Soliman D, Arevalo G, Galindo RJ, Churba B, Malden KG, Jimenez DE, et al. Navigating Continuous Glucose Monitoring Adoption: Insights From Hispanic Adults With Insulin‐Treated Type 2 Diabetes. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/7474846
BibTeX
@article{Soliman2026,
author = {Soliman, Diana and Arevalo, Giuliana and Galindo, Rodolfo J and Churba, Benjamin and Malden, Keilecia G and Jimenez, Daniel E and Pasquel, Francisco J and Baidal, David A and Walker, Ashby F},
title = {Navigating Continuous Glucose Monitoring Adoption: Insights From Hispanic Adults With Insulin‐Treated Type 2 Diabetes},
journal = {Journal of Diabetes Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jdr/7474846}
}
EUVIMED